CGON

NASD CG Oncology, Inc.
Sep 30, 2026 · 5:56 AM ET LAST TRADE Market Closed

$71.00 ↑ +0.48 (+0.68%) Trading Up from the previous close of $70.52

YTD change
+71.00%
vs 20-day SMA
-3.09%
vs 200-day SMA
+11.84%

Price ranges

Previous day
$68.26 $70.68
open $69.56 close $70.52
+$0.96 (+1.38%)
Today
$0.00 $0.00
$71.00
Past week
$66.01 $77.79
from $77.74 now $71.00
-$6.74 (-8.67%)
Past month
$66.01 $80.63
from $75.16 now $71.00
-$4.16 (-5.53%)
This year
$39.14 $80.97
from $41.52 now $71.00
+$29.48 (+71.00%)

Price & Performance

+6.56 (+10.26%) / 6M

$51.56$61.99$72.41$82.84Mar 30Jun 30Sep 29

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Very Good
  • The stock is 12.3% away from all-time highs of $80.97
  • CGON is up 71% since the beginning of the year
  • CGON is up 76% over the past 12 months
  • CGON is down 6% over the past 1 month
  • 20% of all CGON investors are betting against CGON

CGON reads very good: price sits above one of the two key moving averages, the 12-month move is +75.1%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-0.9
Earnings momentum -7.9% Quarterly EPS growth
Quarterly change -7.9%

Valuation

P/E ratio N/A
Enterprise value $5.1B
Beta 0.24

Balance sheet & scale

IncomeN/A
Revenue$6.2M
Cash$1.0B
Debt$8.8K
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Manufacturing
Sub Sector Chemical Manufacturing
Market cap $6.3B

CG Oncology, Inc. is a clinical biopharmaceutical company, which engages in the development and commercialization of bladder-sparing therapeutic patients afflicted with bladder cancer. It offers cretostimogene, a product initially in clinical development for the treatment of patients with Non-Muscle Invasive Bladder Cancer (NMIBC). The company was founded by Alex Yeung and Paul A. DeRidder on September 24, 2010 and is headquartered in Dallas, TX.

Competitor comparison

TickerCompany PriceChange
CSLLY CSL Limited Sponsored ADR $31.91 -0.28%
ARGX argenx SE Sponsored ADR $970.66 -0.16%
ONC BeOne Medicines Ltd. Sponsored ADR $365.27 -0.47%
WXXWY WuXi Biologics (Cayman) Inc. Unsponsored ADR $13.62 -0.29%
INCY Incyte Corporation $123.20 -1.30%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.